carteolol has been researched along with Anochlesia in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Excerpt | Relevance | Reference |
---|---|---|
"Neuroleptic-induced catalepsy, a model of neuroleptic-induced extrapyramidal side effects, was considered suitable as a model for predicting neuroleptic-induced akathisia in humans, although neuroleptic-induced catalepsy was not considered a specific test for neuroleptic-induced akathisia." | 1.30 | The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats. ( Kikuchi, T; Morita, S; Nakai, M; Tottori, K; Uwahodo, Y, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kikuchi, T | 1 |
Uwahodo, Y | 1 |
Tottori, K | 1 |
Nakai, M | 1 |
Morita, S | 1 |
1 other study available for carteolol and Anochlesia
Article | Year |
---|---|
The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats.
Topics: Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Carteolol; Catalepsy; Haloperidol; Locom | 1997 |